The place of digital devices and artificial intelligence in cardiac arrhythmia management: new advances, practical guides, and promising prospects.

Developing digital devices and remote technologies for the diagnosis and management of arrhythmias are revolutionizing cardiologist clinical practice and decision-making. Electrocardiogram (ECG) and plethysmography (PPG)-based devices are widely used to assess cardiac rhythm. Artificial intelligence (AI) enabled devices may contribute to early detection and monitoring of atrial fibrillation (AF), long QT syndrome (LQTS), as well as QTc related adverse drug events. Some other devices such as contactless rhythm monitoring may be useful in ambulatory cardiac arrhythmia mass screening. Keywords Digital device ;Arrhythmia ;Atrial fibrillation ;Artificial intelligence ;Review.